Sumpatan, Baby Girl B.
HRN: 23-35-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2023
CEFOTAXIME 500MG (VIAL)
07/18/2023
07/24/2023
IV
135mg
Q8
Neonatal Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes